Amgen Inc.
Mega Cap · Healthcare · Drug Manufacturers - General
$415.21−$2.63 (-0.63%)
Amgen Inc.
Mega Cap · Healthcare · Drug Manufacturers - General
$415.21−$2.63 (-0.63%)
Stock analysis
Get the AI take on AMGN
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$269.77
High$391.29
Today $415.21
RSI (14)
70.0Overbought
03070100
Overall score
59/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$230
Median target
$388
Current price
$415.21
Highest
$452
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- ROIC: Money put back into the business keeps coming back out as profit, a hallmark of a durable moat.
What to watch
- Debt exceeds cash by $43.3B, increasing balance-sheet pressure, a warning sign.
- Debt / equity: Heavy borrowing means a downturn would hit harder than it otherwise would.
What the market charges
Forward P/E
Favorable · 17% below avg
17.73x
Price / sales
Reasonable · Priced reasonably against its revenue
5.89x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
22.06x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
15.51x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
19.8%
ROE
Favorable · 101.3% - strong capital efficiency
91.5%
Debt / equity
Needs attention · Unfavorable
4.90x
Current ratio
Reasonable · Just enough on hand to cover near-term bills
1.37x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $224.48B | 25.8 | +9.1% | 59 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |